Enterprise Value
654.4M
Cash
178.6M
Avg Qtr Burn
-21.07M
Short % of Float
30.86%
Insider Ownership
4.57%
Institutional Own.
-
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
STK-001 Details Dravet syndrome, Epilepsy | Phase 1/2 Update | |
STK-002 (UK) Details Rare genetic disease, Autosomal Dominant Optic Atrophy | Phase 1/2 Initiation |